Medical Properties Trust (NYSE:MPW) Stock Rating Lowered by Zacks Investment Research

Medical Properties Trust (NYSE:MPW) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday, Zacks.com reports.

According to Zacks, “Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. “

A number of other research analysts also recently weighed in on MPW. Bank of America assumed coverage on Medical Properties Trust in a research note on Monday, October 14th. They issued a “neutral” rating and a $19.50 price objective on the stock. Barclays set a $22.00 price objective on Medical Properties Trust and gave the company a “buy” rating in a research note on Monday, October 21st. SunTrust Banks raised their price objective on Medical Properties Trust from $20.00 to $21.00 and gave the company a “buy” rating in a research note on Tuesday, August 27th. JPMorgan Chase & Co. set a $21.00 price target on Medical Properties Trust and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, TheStreet downgraded Medical Properties Trust from a “b” rating to a “c+” rating in a research report on Monday, November 25th. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Medical Properties Trust has an average rating of “Buy” and an average target price of $20.18.

Shares of MPW stock opened at $20.56 on Tuesday. The stock’s 50 day simple moving average is $20.21 and its 200 day simple moving average is $18.83. The company has a debt-to-equity ratio of 1.02, a quick ratio of 6.27 and a current ratio of 6.27. Medical Properties Trust has a twelve month low of $15.25 and a twelve month high of $21.05. The company has a market capitalization of $10.68 billion, a price-to-earnings ratio of 15.01, a PEG ratio of 3.74 and a beta of 0.51.

Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.20 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.32 by ($0.12). Medical Properties Trust had a net margin of 41.57% and a return on equity of 6.36%. The company had revenue of $224.70 million during the quarter, compared to the consensus estimate of $221.40 million. During the same period in the previous year, the business posted $0.35 earnings per share. The firm’s revenue was up 14.1% on a year-over-year basis. On average, analysts forecast that Medical Properties Trust will post 1.33 EPS for the current fiscal year.

In other Medical Properties Trust news, CFO R Steven Hamner sold 77,500 shares of Medical Properties Trust stock in a transaction that occurred on Wednesday, September 25th. The stock was sold at an average price of $19.43, for a total value of $1,505,825.00. Following the transaction, the chief financial officer now directly owns 1,235,457 shares of the company’s stock, valued at approximately $24,004,929.51. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Holzgrefe Richard purchased 500,000 shares of the company’s stock in a transaction on Friday, November 8th. The stock was acquired at an average cost of $0.09 per share, for a total transaction of $44,500.00. Insiders own 1.18% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Private Ocean LLC bought a new stake in shares of Medical Properties Trust during the third quarter valued at approximately $50,000. Lenox Wealth Advisors LLC bought a new stake in shares of Medical Properties Trust during the third quarter valued at approximately $31,000. Cullen Frost Bankers Inc. increased its position in shares of Medical Properties Trust by 70.9% during the second quarter. Cullen Frost Bankers Inc. now owns 1,832 shares of the real estate investment trust’s stock valued at $32,000 after purchasing an additional 760 shares during the period. Northern Oak Wealth Management Inc. bought a new stake in shares of Medical Properties Trust during the third quarter valued at approximately $51,000. Finally, Bartlett & Co. LLC bought a new stake in shares of Medical Properties Trust during the third quarter valued at approximately $51,000. Institutional investors and hedge funds own 71.94% of the company’s stock.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Further Reading: What are trading strategies for the 52-week high/low?

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.